Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM.
Hailun QinPooja DewanBernadet T SantemaJozine M Ter MaatenKarl SwedbergJohn J V McMurrayAdriaan A Voors
Published in: ESC heart failure (2024)
In a randomized clinical trial in patients with HFrEF, men and women achieved similar doses of candesartan. Primary event rates and treatment-related discontinuation due to adverse events were also similar between men and women.